Provided by Tiger Fintech (Singapore) Pte. Ltd.

Stoke Therapeutics, Inc.

13.22
+0.87007.04%
Post-market: 13.220.00000.00%18:43 EDT
Volume:1.55M
Turnover:20.95M
Market Cap:721.77M
PE:15.08
High:14.50
Open:12.93
Low:12.54
Close:12.35
Loading ...
Feb 14, 2022

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 14, 2022

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 10, 2022

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Jan 24, 2022

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Jan 10, 2022

Major Issues Report

8-K - Current report
Dec 17, 2021

Major Issues Report

8-K - Current report
Dec 03, 2021

Major Issues Report

8-K - Current report
Nov 08, 2021

Major Issues Report

8-K - Current report
Nov 08, 2021

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Sep 21, 2021

Major Issues Report

8-K - Current report
Sep 09, 2021

Major Issues Report

8-K - Current report
Aug 10, 2021

Major Issues Report

8-K - Current report
Aug 10, 2021

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Jun 30, 2021

Beneficial Ownership Change

SC 13D - General statement of acquisition of beneficial ownership
Jun 29, 2021

Beneficial Ownership Change

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
Jun 09, 2021

Major Issues Report

8-K - Current report
May 14, 2021

[Rev.]Quaterly Report

10-Q/A [Amend] - Quarterly report [Sections 13 or 15(d)]
May 10, 2021

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
May 10, 2021

Major Issues Report

8-K - Current report
Mar 19, 2021

Employee Stock Ownership

S-8 - Securities to be offered to employees in employee benefit plans